Markets:

Overview

News

Currencies

International

Treasuries

Novavax, Inc. - Common Stock (NQ:NVAX)

8.700 +0.280 (+3.33%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

65 66 Next >

Has Novavax Just Solved Its Biggest Problem? ↗

February 27, 2024

The biotech company recently settled a dispute with a major customer.

Via The Motley Fool

Novavax’s dispute resolution and upcoming earnings call

February 23, 2024

Novavax navigates legal settlements, earnings expectations, and competition, hoping their protein-based vaccines become a global health game-changer.

Via MarketBeat

Topics Earnings

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 22, 2024

Via Benzinga

NICE Posts Upbeat Earnings, Joins FTI Consulting, NVIDIA, Moderna And Other Big Stocks Moving Higher On Thursday ↗

February 22, 2024

U.S. stocks were higher, with the Nasdaq Composite gaining more 2% on Thursday.

Via Benzinga

Topics Stocks

Better Bull Market Buy: Novavax vs. Pfizer ↗

February 22, 2024

Bull markets usually favor stocks with promising growth prospects.

Via The Motley Fool

Where Will Novavax Be in 10 Years? ↗

February 15, 2024

Without any windfalls on the horizon, times are dire for this biotech.

Via The Motley Fool

Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 22, 2024

Shares of Etsy, Inc.

Via Benzinga

Morgan Stanley Is Pounding the Table on DoorDash (DASH) Stock ↗

February 22, 2024

DoorDash stock is rising higher on Thursday after Morgan Stanley upgraded DASH shares and increased their price target for them.

Via InvestorPlace

Morgan Stanley Issues a Warning on Rivian (RIVN) Stock ↗

February 22, 2024

Rivian stock is falling hard on Friday as RIVN investors react to a warning from Morgan Stanley and a weak EV production guidance for 2024.

Via InvestorPlace

Better Recovery Story Buy: Novavax vs. Teladoc ↗

February 03, 2024

Both stocks have fallen more than 90% from their peak.

Via The Motley Fool

Could Novavax Stock Help You Become a Millionaire? ↗

February 01, 2024

Novavax aims to win with its coronavirus/flu vaccine candidate, now in clinical trials.

Via The Motley Fool

Looking Into Novavax's Recent Short Interest ↗

January 31, 2024

Via Benzinga

What's Going On With Novavax Stock Today? ↗

February 22, 2024

Novavax said it reached a settlement with Gavi related to the 2021 advance purchase agreement for Novavax's prototype COVID-19 vaccine. The agreement brings the pending arbitration related to the...

Via Benzinga

NVAX Stock Climbs as Novavax Settles Covid-19 Vaccine Dispute ↗

February 22, 2024

Novavax stock is climbing higher on Thursday as investors in NVAX shares react to it reaching a $475 million settlement with Gavi.

Via InvestorPlace

Get Rich Quick With These 3 Stocks to Buy Now ↗

February 15, 2024

Although these market ideas are extremely speculative, their upcoming catalysts could make them stocks to buy now.

Via InvestorPlace

3 Doomed Biotech Stocks to Dump Before They Dive: February 2024 ↗

February 11, 2024

Spot the looming risks in the biotech sector and avoid these three doomed biotech stocks likely to burn shareholder value significantly.

Via InvestorPlace

3 Beaten-Down Growth Stocks that Could Take off in the New Bull Market ↗

February 05, 2024

Bull markets favor growth stocks so now could be the time for these players to shine.

Via The Motley Fool

Is It Too Late to Buy Novavax Stock? ↗

January 28, 2024

The biotech could fade into irrelevance soon.

Via The Motley Fool

Where Will Novavax Be in 5 Years? ↗

January 27, 2024

Can the beaten-down stock turn things around?

Via The Motley Fool

Novavax's Malaria Vaccine Gets WHO Prequalification, Has Potential Of Being An Affordable Option ↗

February 02, 2024

Novavax's R21/Matrix-M malaria vaccine, with 75% efficacy in seasonal areas. Affordable at $3 per dose, it outshines GSK's vaccine. Global rollout expected mid-2024.

Via Benzinga

Novavax Layoffs 2024: What to Know About the Latest NVAX Job Cuts ↗

January 31, 2024

The Novavax layoffs are coming for 12% of the company's global workforce. However, NVAX stock itself could shock the market.

Via InvestorPlace

Topics Workforce

3 Under-the-Radar Stocks With 340% to 762% Upside in 2024, According to Select Wall Street Analysts ↗

January 31, 2024

If a trio of Wall Street analysts is correct, three lesser-known stocks could skyrocket in the new year.

Via The Motley Fool

1 Reason to Buy Novavax Stock, and 3 (Better) Reasons to Sell ↗

January 29, 2024

This biotech isn't at the end of the road just yet, but don't bet on a revival.

Via The Motley Fool

1 Reason to Buy Novavax Stock Hand Over Fist and 1 Reason to Sell ↗

January 28, 2024

The stock is high risk, but rewards could be great if all works out well for Novavax.

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

January 23, 2024

Via Benzinga

Novavax Stock May Soar 379%, According to Wall Street. Is the Stock a Buy Right Now? ↗

January 23, 2024

Novavax faces a couple of key issues that could be crucial for the stock price.

Via The Motley Fool

5 Stocks With Short Interest Over 40%: Possible Short Squeeze Plays ↗

January 21, 2024

Short selling can be profitable, but sometimes when the stock moves against short sellers and begins to rise, the short sellers jump in to buy shares to cover their positions, creating what is called a...

Via Talk Markets

Are You Kidding Me? 3 Meme Stocks You Should Have Already Sold ↗

January 15, 2024

Be sure to sell these meme stocks as they represent fundamentally weak businesses that will continue to erode in value.

Via InvestorPlace

Time to Buy These 3 Stocks That Just Hit a 52-Week Low? ↗

January 15, 2024

Sometimes buying stocks at a 52-week low is a chance to buy a good company at great prices but you need to see if the business is busted.

Via InvestorPlace

3 Turnaround Stocks With 151% to 600% Upside in 2024, According to Select Wall Street Analysts ↗

January 09, 2024

High-water price targets from select analysts imply triple-digit gains in the new year for three former highfliers.

Via The Motley Fool

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

65 66 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Novavax, Inc. - Common Stock (NQ:NVAX)

All News about Novavax, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today